Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

The potential sale would accelerate J&J’s portfolio reshaping while giving Apollo a major foothold in orthopedic medical devices.

Shares gained after reports that Apollo is weighing a purchase of DePuy Synthes as J&J prepares to separate the business.